![]() |
Volumn 8, Issue 12, 2007, Pages 1273-1276
|
Science, medicine and research in the developing world: A perspective
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFRICA;
CLINICAL TRIAL;
COST OF LIVING;
DEVELOPING COUNTRY;
DIAGNOSTIC TEST;
DRUG COST;
ECONOMIC EVALUATION;
GOVERNMENT REGULATION;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HEALTH EDUCATION;
HEALTH PRACTITIONER;
HEALTH PROGRAM;
HEALTH SCIENCE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INDIA;
KENYA;
LIFE EXPECTANCY;
MEDICAL RESEARCH;
MEDICAL TECHNOLOGY;
MEDICINE;
NOTE;
PANDEMIC;
POVERTY;
PRACTICE GUIDELINE;
PREVALENCE;
PREVENTIVE HEALTH SERVICE;
PRIORITY JOURNAL;
SOUTH AFRICA;
UGANDA;
UNITED KINGDOM;
ZIMBABWE;
AIDS VACCINES;
BIOMEDICAL RESEARCH;
DEVELOPING COUNTRIES;
MEDICINE;
SCIENCE;
|
EID: 36248946190
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni1531 Document Type: Note |
Times cited : (12)
|
References (22)
|